CI
Capital International Portfolio holdings
AUM
$2.61B
This Quarter Return
+2.21%
1 Year Return
+36.08%
3 Year Return
+158.9%
5 Year Return
+280.54%
10 Year Return
+783.6%
AUM
$1.7B
AUM Growth
+$1.7B
(+3.4%)
Cap. Flow
+$34.5M
Cap. Flow
% of AUM
2.03%
Top 10 Holdings %
Top 10 Hldgs %
27.59%
Holding
194
New
16
Increased
27
Reduced
56
Closed
3
Top Buys
| 1 |
Eli Lilly
LLY
|
$23.2M |
| 2 |
Alphabet (Google) Class C
GOOG
|
$22M |
| 3 |
Starbucks
SBUX
|
$15.3M |
| 4 |
VALE.P
Vale S A
VALE.P
|
$15.2M |
| 5 |
Wynn Resorts
WYNN
|
$9.67M |
Top Sells
| 1 |
Bristol-Myers Squibb
BMY
|
$23.5M |
| 2 |
Vale
VALE
|
$17.3M |
| 3 |
Merck
MRK
|
$17M |
| 4 |
LyondellBasell Industries
LYB
|
$11.5M |
| 5 |
VeriSign
VRSN
|
$9.45M |
Sector Composition
| 1 | Healthcare | 16.55% |
| 2 | Financials | 15.8% |
| 3 | Technology | 11.73% |
| 4 | Consumer Discretionary | 8.71% |
| 5 | Energy | 8.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Goldman Sachs
GS
$226B
| $76.8M | 4.53% | 368,000 | – | – |
|
2
Microsoft
MSFT
$3.77T
| $59M | 3.48% | 1,336,232 +49,200 | +4% | +$2.17M |
|
3
Incyte
INCY
$16.5B
| $54.8M | 3.23% | 526,000 -28,300 | -5% | -$2.95M |
|
4
Gilead Sciences
GILD
$140B
| $50.6M | 2.98% | 431,850 | – | – |
|
5
CME Group
CME
$96B
| $42.5M | 2.51% | 456,700 | – | – |
|
6
Newell Brands
NWL
$2.48B
| $40M | 2.36% | 973,750 -25,400 | -3% | -$1.04M |
|
7
Apple
AAPL
$3.45T
| $39.1M | 2.3% | 311,459 | – | – |
|
|
8
Alphabet (Google) Class C
GOOG
$2.58T
| $37.8M | 2.23% | 71,446 +41,672 | +140% | +$22M |
|
9
Wells Fargo
WFC
$263B
| $34M | 2.01% | 605,300 +2,400 | +0.4% | +$135K |
|
10
ConocoPhillips
COP
$124B
| $33.2M | 1.96% | 541,260 +12,400 | +2% | +$761K |
|
|
11
Starbucks
SBUX
$100B
| $30.7M | 1.81% | 571,948 +286,199 | +100% | +$15.3M |
|
12
Visa
V
$683B
| $30.5M | 1.8% | 453,880 | – | – |
|
13
Eaton
ETN
$136B
| $30M | 1.77% | 444,100 | – | – |
|
14
Danaher
DHR
$147B
| $29.6M | 1.75% | 346,300 | – | – |
|
|
RCPT
15
DELISTED
RECEPTOS INC COM STK (DE)
RCPT
| $28.9M | 1.71% | 152,300 -23,000 | -13% | -$4.37M |
|
16
Digital Realty Trust
DLR
$57.2B
| $25M | 1.47% | 1,177,640 | – | – |
|
17
Royal Caribbean
RCL
$98.7B
| $24.8M | 1.46% | 314,700 | – | – |
|
18
Marsh & McLennan
MMC
$101B
| $24.5M | 1.45% | 432,100 -2,000 | -0.5% | -$113K |
|
19
Chevron
CVX
$324B
| $24.4M | 1.44% | 252,707 -5,800 | -2% | -$560K |
|
|
20
Bristol-Myers Squibb
BMY
$96B
| $24.1M | 1.42% | 361,615 -352,635 | -49% | -$23.5M |
|
21
American Tower
AMT
$95.5B
| $23.8M | 1.41% | 255,400 | – | – |
|
|
22
Eli Lilly
LLY
$657B
| $23.2M | 1.37% | +277,400 | New | +$23.2M |
|
23
Schlumberger
SLB
$55B
| $22.6M | 1.34% | 262,696 -8,200 | -3% | -$707K |
|
|
MON
24
DELISTED
Monsanto Co
MON
| $22.2M | 1.31% | 208,500 +60,400 | +41% | +$6.44M |
|
|
STJ
25
DELISTED
St Jude Medical
STJ
| $22.1M | 1.31% | 302,940 +58,250 | +24% | +$4.26M |
|